Latif Peracha
General Partner @ M13
New York, United States
Latif Peracha is a Series A investor at M13 in New York focused on Software and Financial Services. As M13’s General Partner, Latif manages the investing strategy for the firm and has led numerous deals across money, health, and web3 verticals. He was previously a Managing Director at Virgin Group where he led investing in the Americas.
- Total investments:
- 25
- Last investment:
- Lead investor:
- 56%
Last updated:
For AI agents: llms.txt
Industries Latif Peracha invests in
Stages Latif Peracha invests in
Countries Latif Peracha invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 5 (20%)
- Financial Services 5 (20%)
- FinTech 4 (16%)
- Health Care 4 (16%)
- Blockchain 3 (12%)
Stage
- Series A 10 (40%)
- Seed 8 (32%)
- Series B 5 (20%)
- Pre-Seed 1 (4%)
- Venture - Series Unknown 1 (4%)
Country
- United States 14 (56%)
- Canada 2 (8%)
- Australia 1 (4%)
- Singapore 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| OpenFX is redefining the future of global money movement. We enable money to flow across borders as effortlessly as data, unbound by time zones, legacy systems, or banking hours. Our FX infrastructure transforms how finance teams operate, delivering cross-border transfers with industry-leading spreads, real-time settlement and 24/7availability. We are a team of serial entrepreneurs from Affirm, BofA, Charles Schwab, Goldman Sachs, Intuit, JPM, Kraken, Microsoft, Meta, PayPal, and Slack. | $94M / Series A / Mar 31, 2026 | ||
| ZAR establishes a connection between cash-based economies and the web3 framework, facilitating adoption of stablecoins. | $7M / Seed / Apr 30, 2025 | ||
| AvatarOS is developing the next evolution in interactive human avatars that reach the quality of real life, empowering creators to engage a human audience with the efficiency of artificial intelligence and the authenticity of human individuality. | $7M / Seed / Mar 06, 2025 | ||
| RadiantGraph is on a mission to make healthcare more accessible and user-friendly for all of us. AI technology assists top healthcare organizations in developing deeper and more meaningful connections with their patients, resulting in tailored engagement and therapeutic outcomes. | $11M / Series A / Oct 10, 2024 | ||
| Form Health is the national leader in science-based obesity care, offering a clinical care model that consists of one-on-one, personalized care from a dedicated ABOM-certified physician and a CSOWM-certified Registered Dietitian. The company develops individualized treatment plans that address nutrition, physical activity, mindset shifts, andinclude a prescription for FDA-approved medication, if appropriate, keeping safety, efficacy, and outcomes at the forefront. | $38M / Series B / Jun 26, 2024 | ||
| Code is a Canadian payment platform provider that makes it simple for web developers to collect modest payments from consumers worldwide. | $6.5M / Seed / Feb 06, 2024 | ||
| Carenostics provides underdiagnosis, undertreatment, and health inequities of chronic disease treatment using AI & ML. | $5M / Seed / Sep 13, 2023 | ||
| Polimorphic is an AI-powered government technology platform that helps local and federal governments automate citizen services. It provides AI chat, voice agents, CRM, and workflow tools to handle public requests and service delivery. The platform improves efficiency by reducing manual work and enabling 24/7 digital access to governmentservices. | $5.6M / Seed / Aug 01, 2023 | ||
| Nori is a carbon dioxide removal marketplace. It is building a transparent and secure platform that will allow anyone in the world to pay to remove excess carbon dioxide from the atmosphere. Their voluntary marketplace will enable carbon removal suppliers to connect directly with buyers, improving efficiency, and reducing costs. | $6.3M / Venture - Series Unknown / Jun 06, 2023 | ||
| Canvas Medical is a healthcare platform that supports independent primary care practices. The platform streams clinical data from practices to health plans at an unprecedented level of granularity. For practices, Canvas incorporates claims data from health plans directly into practice management and charting workflows. | $24M / Series B / Jul 14, 2022 | ||
| See all 25 investments → | |||
Co-Investors
About M13
M13 provides strategic counsel and operational expertise to help founders grow their companies. Through Fund II, M13 will expand its focus to emerging technologies driving change in consumer behavior over the next decade. Founded in 2016 with offices in Los Angeles, New York, and San Francisco.
M13 Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Christine Choi
Partner
|
|||
Courtney Reum
Partner, Co-Founder
|
|||
Karl Alomar
Managing Partner
|
|||
|
Latif Peracha
General Partner
|
|||
Matt Hoffman
Partner, Head of Talent
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Latif Peracha invest in?
Latif Peracha invests primarily in Software, Financial Services and FinTech startups, most often at Series A and Seed stage. Most of the 25 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Latif Peracha?
Public channels for Latif Peracha include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Latif Peracha last invest?
The most recent investment recorded for Latif Peracha closed in Mar 2026. Shizune tracks 25 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
